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The growth arrest-speciﬁc 2 (GAS2) was cloned and found to be
upregulated in the feces of recurrent CRC patients. This over-
expressed GAS2 induced different patterns of gene expressions in
CRC cells. Brieﬂy, one cell proliferation marker, Ki-67 antigen
(Ki-67), was upregulated in the cells with overexpressed GAS2,
“Correlation between proliferation markers: PCNA, Ki-67, MCM-2
and antiapoptotic protein Bcl-2 in colorectal cancer” [1]. Whereas,
the expression of another cell proliferation marker, proliferating
cell nuclear antigen (PCNA), changed insigniﬁcantly [1]. In addi-
tion, the mRNA level of one cyclin involving in both cell cycle G1/S
and G2/M transitions was also not affected by GAS2 over-
expression, “Cdc20 and Cks direct the spindle checkpoint-
independent destruction of cyclin A” [2]. The experimentalvier Inc. This is an open access article under the CC BY license
/j.bbadis.2016.04.010










C.-C. Chang et al. / Data in Brief 8 (2016) 82–86 83design and procedures in this article can be helpful for under-
standing the molecular signiﬁcance of GAS2 in SW480 and SW620
CRC cells.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc
subject areaMolecular medicineype of data Table, ﬁgure
ow data was
acquiredThe commercial kit, real-time PCR, SPSS 22.0 for Window softwareata format Filtered, analyzed
xperimental
factorsCRC patients with different clinical status (recurrence and nonrecurrence)
were enrolled. CRC cell lines, SW480 and SW620, were collected for further
transfection.xperimental
featuresFecal total RNA was puriﬁed from these CRC patients with different clinical
status and microarray analyses were performed. In addition, PCNA, Ki-67, and
CCNA2 were quantiﬁed by real-time PCR from SW480 and SW620 CRC cells
according to their GAS2 expressions.ata source
locationNew Taipei, Taiwan, Republic of Chinaata accessibility Data are presented in this articleD
Value of the data
 Expression levels of certain genes in feces were different between CRC patients without and with
recurrence.
 The data would be valuable to correlate the cell proliferation markers and the expression levels
of GAS2.
 The data might support the irrelevance of GAS2 in G2 phase of cell cycle.1. Data
The data shared in this article are the experimental analyses of GAS2 expression in clinical sam-
ples, patient's feces, and CRC cell lines. The level of GAS2 would be up-regulated in the cases with
recurrent CRC by microarray analysis (Fig. 1) [3]. The relative mRNA levels of interested genes (pro-
liferating cell nuclear antigen: PCNA; Ki-67 antigen: Ki-67; cyclin A2: CCNA2) in different cells are
presented in Figs. 2 and 3.2. Experimental design, materials and methods
2.1. Expression difference in feces of nonrecurrent and recurrent CRC patients
Candidates in feces of recurrent patients were clustered from each comparison in relative to those
fecal expressions of non-recurrent patients. The case numbers and stages in these bioinformatic
analyses were 15 non-recurrent patients (6 stage I, 5 stage II, and 4 stage III) and 3 recurrent patients
Fig. 2. mRNA levels of proliferation markers in GAS2-overexpressed SW480 cells. Relative value of mRNA levels was indicated
at bar top. SW480-C3, SW480 cells with pEGFP C3; SW480-C3.GAS2, SW480 cells with GAS2-contained pEGFP C3. PCNA,
proliferating cell nuclear antigen; Ki-67, Ki-67 antigen; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GAS2, growth
arrest-speciﬁc-2. SW480, ATCC CCL-228. *Po0.05.
Fig. 1. Clusters of 22 signiﬁcant genes for recurrent CRC. The relative fold and statistic signiﬁcance in these assays were set at
41.5-fold and Po0.05 on the similarity between their expressions in cases. Values of high (red) and low (green) expressions
were indicated at lower right corner.
C.-C. Chang et al. / Data in Brief 8 (2016) 82–8684(stage III). Candidates in CRC tissues were extracted from GEO: GSE17536, GEO: GSE17537, GEO:
GSE17538_GPL570 (Mofﬁtt Cancer Center and Vanderbilt University Medical Center, respectively),
GEO: GSE12032 (individual comparison at each stage for non-recurrent vs. recurrent), and GEO:
GSE27854 at the public website of Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) [4–7].
Genes with potentially signiﬁcant changes were selected by comparing the data from non-recurrent
and recurrent CRC tissues. 22 genes were selected due to the cross-compared results from fecal and
CRC tissue microarrays.
Fig. 3. mRNA levels of CCNA2 in relation to GAS2 overexpression. Relative value of mRNA levels was indicated at bar top.
SW480-C3, SW480 cells with pEGFP C3; SW480-C3.GAS2, SW480 cells with GAS2-contained pEGFP C3. CCNA2, cyclin A2;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GAS2, growth arrest-speciﬁc-2. SW480, ATCC CCL-228; SW620, ATCC
CCL-227.
Table 1
Primers for cloning growth arrest-speciﬁc 2 into pAS4.1w.Ppuro-aOn plasmid.
Ofﬁcial symbol Accession Sequence (from 5' to 3')a Product size
GAS2 NM_005256 F: GCGATCGCGCTAGCATGTGCACTGCTCTGAGCCC 964bp
R: GTTTAAACTCACTTAATTTCCTTCTTAGCCT
Abbreviations: GAS2, growth arrest-speciﬁc 2; F, forward primer; R, reverse primer; pAS4.1w.Ppuro-aOn, all-in-one tetra-
cycline-inducible plasmid.
a Underline indicated the AsiSI restriction site at forward primer and the PmeI restriction site at reverse primer; start codon
(ATG) and stop codon (TGA; reverse sequence: TCA) were in bold letters.
C.-C. Chang et al. / Data in Brief 8 (2016) 82–86 852.2. The signiﬁcance of GAS2 in cell proliferation
We established two SW480 cell lines to overexpress GAS2. Firstly, GAS2 cDNA was ampliﬁed from
a human placenta library (Sigma-Aldrich, St. Louis, MO, USA) (Table 1) and the polymerase chain
reaction (PCR) bands for GAS2 were sequenced to conﬁrm gene identity. Then, SW480 cells expres-
sing GAS2 were generated either by lentiviral transduction using the all-in-one tetracycline-inducible
plasmid (pAS4.1w.Ppuro-aOn) (Academia Sinica, Taipei, Taiwan) or by stable transfection using a
plasmid encoding green ﬂuorescent protein (pEGFP C3) (Takara Bio, Shiga, Japan).
The relative mRNA levels of PCNA (NM_002592) and Ki-67 (NM_002417) in cells were quantiﬁed
by quantitative real-time PCR and relative to the mRNA level of GAPDH (NM_002046). As shown in
Fig. 2, the level of Ki-67 in SW480-C3.GAS2 was signiﬁcantly higher than that in control cells without
GAS2 overexpression (SW480-C3). Primer sequences used in these gene quantiﬁcations were
C.-C. Chang et al. / Data in Brief 8 (2016) 82–8686described as following: PCNA (universal probe, #69), 50-TGGAGAACTTGGAAATGGAAA-30 for forward
primer and 50-GAACTGGTTCATTCATCTCTATGG-30 for reverse primer; Ki-67 (universal probe, #73), 50-
CAAGAGGTGTGCAGAAAATCC-30 for forward primer and 5’-TCACTGTCCCTATGACTTCTGG-30 for reverse
primer. The expression level of GAPDH (universal probe, #60; forward primer, 50-
CTCTGCTCCTCCTGTTCGAC-30; reverse primer, 50-ACGACCAAATCCGTTGACTC-30) was used as an
internal control for calibration.
2.3. The correlation of GAS2 in the expression of CCNA2
The molecular marker for G2 phase of cell cycle, CCNA2 (NM_001237), was speciﬁc quantiﬁed by
quantitative real-time PCR. The relative mRNA levels of CCNA2 were also calibrated with that of
GAPDH as described before. However, no signiﬁcant difference was found in the cells with over-
expressed GAS2 (Fig. 3). Sequences of primer pair for CCNA2 were 50-CCATACCTCAAGTATTTGCCATC-
30 (forward primer) and 50-TCCAGTCTTTCGTATTAATGATTCAG-30 (reverse primer). The number of
universal was #67.Acknowledgments
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